Interim Recommendations of the Advisory Committee on Immunization Practices for Use of Moderna and Pfizer-BioNTech COVID-19 Vaccines in Children Aged 6 Months–5 Years — United States, June 2022 July 1, 2022June 30, 2022
Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5–17 Years — VISION Network, 10 States, April 2021–January 2022 March 3, 2022
Pfizer-BioNTech vaccine effectiveness wanes for children 5 to 11, but still protects against serious outcomes, CDC data show March 2, 2022March 1, 2022
Pfizer/BioNTech, Moderna expect data on shot’s protection against new COVID-19 variant soon November 26, 2021
Pfizer/BioNTech COVID-19 vaccine effectiveness drops after 6 months, study shows October 5, 2021October 4, 2021
FDA Authorizes Booster Dose of Pfizer-BioNTech COVID-19 Vaccine for Certain Populations September 23, 2021September 22, 2021
US Coronavirus: Full FDA approval for the Pfizer/BioNTech vaccine will likely drive up vaccination rates, experts say August 22, 2021